Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Nuo Therapeutics, Inc. | v423183_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - Nuo Therapeutics, Inc. | v423183_ex31-2.htm |
| EX-10.78 - EXHIBIT 10.78 - Nuo Therapeutics, Inc. | v423183_ex10-78.htm |
| EX-31.1 - EXHIBIT 31.1 - Nuo Therapeutics, Inc. | v423183_ex31-1.htm |
| EX-10.77 - EXHIBIT 10.77 - Nuo Therapeutics, Inc. | v423183_ex10-77.htm |
| 10-Q - 10-Q - Nuo Therapeutics, Inc. | v423183_10q.htm |
| EX-10.76 - EXHIBIT 10.76 - Nuo Therapeutics, Inc. | v423183_ex10-76.htm |
Exhibit 32.1
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. §1350 and in connection with the Quarterly Report on Form 10-Q of Nuo Therapeutics, Inc. (the “Company”) for the period ended September 30, 2015 (the “Report”), I, Dean Tozer, Chief Executive Officer of the Company, hereby certify, that, to my knowledge:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: November 12, 2015 | /s/ Dean Tozer | |
| Dean Tozer | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) |